UROAMPLITUDE Trademark

Trademark Overview

On Wednesday, February 10, 2021, a trademark application was filed for UROAMPLITUDE with the United States Patent and Trademark Office. The USPTO has given the UROAMPLITUDE trademark a serial number of 90523219. The federal status of this trademark filing is REGISTERED as of Tuesday, November 8, 2022. This trademark is owned by Convergent Genomics, Inc.. The UROAMPLITUDE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical testing for diagnostic or treatment purposes in the field of cancer; medical diagnostic testing, monitoring and reporting services in the field of cancer; providing cancer screening services
uroamplitude

General Information

Serial Number90523219
Word MarkUROAMPLITUDE
Filing DateWednesday, February 10, 2021
Status700 - REGISTERED
Status DateTuesday, November 8, 2022
Registration Number6896300
Registration DateTuesday, November 8, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 26, 2022

Trademark Statements

Pseudo MarkURO AMPLITUDE
Goods and ServicesMedical testing for diagnostic or treatment purposes in the field of cancer; medical diagnostic testing, monitoring and reporting services in the field of cancer; providing cancer screening services

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, May 15, 2021
Primary Code044
First Use Anywhere DateThursday, March 3, 2022
First Use In Commerce DateThursday, March 3, 2022

Trademark Owner History

Party NameConvergent Genomics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameConvergent Genomics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameConvergent Genomics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Monday, February 15, 2021NEW APPLICATION ENTERED
Monday, March 7, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, May 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 4, 2021ASSIGNED TO EXAMINER
Monday, September 13, 2021NON-FINAL ACTION E-MAILED
Monday, September 13, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 13, 2021NON-FINAL ACTION WRITTEN
Monday, March 7, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 8, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, March 20, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 6, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 27, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, April 26, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 26, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 21, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, August 11, 2022NON-FINAL ACTION E-MAILED
Monday, June 27, 2022USE AMENDMENT FILED
Tuesday, July 19, 2022STATEMENT OF USE PROCESSING COMPLETE
Tuesday, July 19, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 11, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 11, 2022SU - NON-FINAL ACTION - WRITTEN
Monday, August 15, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 20, 2022ASSIGNED TO LIE
Tuesday, September 20, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 20, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 30, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, October 1, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 8, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, November 8, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Friday, June 28, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 28, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 28, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Related Keywords

uroamplitude cancer services medical field diagnostic testing providing screening monitoring treatment